David D. Chang

President and CEO at Allogene Therapeutics · 1 reported transaction in 1 company · latest trade Feb 2, 2026

Their trades


Allogene TherapeuticsALLO	Sold $171.5K · 95,269 shares	Feb 2, 2026	S&P 500 +8.7%thru Oct 30

Feb 2, 2026 · ALLO

$171.5K

S&P 500 +8.7%thru Oct 30

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

President and CEO at Allogene Therapeutics · 1 reported transaction in 1 company · latest trade Feb 2, 2026


Allogene TherapeuticsALLO	Sold $171.5K · 95,269 shares	Feb 2, 2026	S&P 500 +8.7%thru Oct 30

Feb 2, 2026 · ALLO

$171.5K

S&P 500 +8.7%thru Oct 30

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.